Access cutting-edge phenylketonuria (pku) and hyperphenylalaninemia treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Chicago location
Preparing your pre-screening questions…
Access phenylketonuria (pku) and hyperphenylalaninemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related phenylketonuria (pku) and hyperphenylalaninemia treatment provided free
Check if you qualify for this phenylketonuria (pku) and hyperphenylalaninemia clinical trial in Chicago, IL
No-Cost Study Care
Local to Chicago
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this observational study is to evaluate the performance of the PheCheck™ test for the rapid detection of phenylalanine (Phe) from a fingerstick sample, in patients 1 year or older with phenylketonuria (PKU) or hyperphenylalaninemia. The main objective is comparing the concentration of phenylalanine (Phe) in capillary blood with the reference method (DBS).
Sponsor: Aptatek BioSciences, Inc
Yes, this clinical trial (NCT07551921) has an active research site in Chicago, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for phenylketonuria (pku) and hyperphenylalaninemia treatment options in Chicago, IL, this clinical trial (NCT07551921) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced phenylketonuria (pku) and hyperphenylalaninemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all phenylketonuria (pku) and hyperphenylalaninemia clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Chicago — not just this study.
Browse Heart Attack Trials in Chicago →